The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 12, 2013, Pages 5912-5917

  Banerjee, Ritu ^a   Johnston, Brian ^b   Lohse, Christine ^a   Chattopadhyay, Sujay ^c   Tchesnokova, Veronika ^c   Sokurenko, Evgeni V ^c   Johnson, James R ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT; BACTERIAL DNA;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; CLONING; EPIDEMIOLOGICAL DATA; ESCHERICHIA COLI INFECTION; EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI; FEMALE; FIMH GENE; FUMC GENE; GENE SEQUENCE; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIAL DIVERSITY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; AGE; AGED; CELL CLONE; CLASSIFICATION; DRUG EFFECTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETIC VARIABILITY; GENETICS; HOST RANGE; INFANT; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; NEWBORN; PRESCHOOL CHILD; UNITED STATES; VERY ELDERLY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLONE CELLS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENETIC VARIATION; HOST SPECIFICITY; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MINNESOTA; MULTILOCUS SEQUENCE TYPING;

EID: 84887444056     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01065-13     Document Type: Article

References (27)

1. O'Neill O, Talboys C, Roberts A, Azadian B. 1990. The rise and fall of Escherichia coli O15 in a London teaching hospital. J. Med. Microbiol. 33:23-27.
2. Johnson J, Manges A, O'Bryan T, Riley L. 2002. A disseminated multidrug-resistant clonal group of uropathogenic Escherichia coli in pyelonephritis. Lancet 359:2249-2251.
3. Manges A, Johnson J, Foxman B, O'Bryan T, Fullerton K, Riley L. 2001. Widespread distribution of urinary tract infections caused by a multidrugresistant Escherichia coli clonal group. N. Engl. J. Med. 345:1007-1013.
4. Olesen B, Scheutz F, Menard M, Skov M, Kolmos H, Kuskowski M, Johnson J. 2009. Three-decade epidemiological analysis of Escherichia coli O15:K52:H1. J. Clin. Microbiol. 47:1857-1862.
5. Johnson J, Menard M, Johnston B, Kuskowski M, Nichol K, Zhanel G. 2009. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002-2004. Antimicrob. Agents Chemother. 53:2733-2739.
6. Coque T, Baquero F, Canton R. 2008. Increasing prevalence of ESBLproducing Enterobacteriaceae in Europe. Euro Surveill. 13:1-11.
7. Platell J, Cobbold R, Johnson J, Trott D. 2010. Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia. J. Antimicrob. Chemother. 65:1936-1938.
8. Johnson J, Johnston B, Clabots C, Kuskowski M, Castanheira M. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 51:286-294.
9. Cagnacci S, Gualco L, Debbia E, Schito G, Marchese A. 2008. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25: H4-ST131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J. Clin. Microbiol. 46:2605-2612.
10. Nicolas-Chanoine M-H, Blanco J, Leflon-Guibout V, Demarty R, Alonso M, Canica MM, Park Y-J, Lavigne J-P, Pitout J, Johnson J. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281.
11. Peirano G, Costello M, Pitout J. 2010. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals. Int. J. Antimicrob. Agents 36:19-23.
12. Johnson J, Tchesnokova V, Johnston B, Clabots C, Roberts P, Billig M, Riddell K, Rogers P, Qin X, Butler-Wu S, Price L, Aziz M, Nicolas-Chanoine M, Debroy C, Robicsek A, Hansen G, Urban C, Platell J, Trott D, Zhanel G, Weissman S, Cookson B, Fang F, Limaye A, Scholes D, Chattopadhyay S, Hooper D, Sokurenko E. 2013. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J. Infect. Dis. 207:919-928.
13. Banerjee R, Johnston B, Lohse C, Porter S, Clabots C, Johnson J. 2013. Escherichia coli sequence type ST131 is a dominant, antimicrobialresistant clonal group associated with healthcare and elderly hosts. Infect. Control Hosp. Epidemiol. 34:361-369.
14. CTX-M-15 among extended spectrum beta-lactamase producing E. coli from the United States, 2000-2009. Antimicrob. Agents Chemother. 56:2364-2370.
15. Blanco M, Alonso MP, Nicolas-Chanoine M-H, Dhabi G, Mora A, Blanco JE, Lopez C, Cortex P, Llagostera M, Leflon-Guibout V, Puentes B, Mamani R, Herrera A, Coira MA, Garcia-Garrote F, Pita JM, Blanco J. 2009. Molecular epidemiology of Escherichia coli producing extendedspectrum beta lactamases in Lugo (Spain): dissemination of clone O25b: H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 63:1135-1141.
16. Croxall G, Hale J, Weston V, Manning G, Cheetham P, Achtman M, McNally A. 2011. Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings. J. Antimicrob. Chemother. 66:2501-2508.
17. Adams-Sapper S, Diep B, Perdreau-Remington F, Riley L. 2013. Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections. Antimicrob. Agents Chemother. 57:490-497.
18. Manges A, Tabor H, Tellis P, Vincent C, Tellier P-P. 2008. Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections. Emerg. Infect. Dis. 14:1575-1583.
19. Gibreel T, Dodgson A, Cheesbrough J, Fox A, Bolton F, Upton M. 2012. Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J. Antimicrob. Chemother. 67:346-356.
20. Weissman S, Johnson J, Tchesnokova V, Billig M, Dykhuizen D, Riddell K, Rogers P, Qin X, Butler-Wu S, Cookson B, Fang F, Scholes D, Chattopadhyay S, Sokurenko E. 2012. High resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl. Environ. Microbiol. 78:1353-1360.
21. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing; nineteeth informational supplement (M100-S19). Clinical and Laboratory Standards Institute, Wayne, PA.
22. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement, CLSI document M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
23. Sahm D, Thornsberry C, Mayfield D, Jones M, Karlowsky J. 2001. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob. Agents Chemother. 45:402-406.
24. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66: 4555-4558.
25. Simpson E. 1949. Measurement of diversity. Nature 163:688.
26. Chattopadhyay S, Feldgarden M, Weissman S, Dykhuizen D, Belle Gv, Sokurenko E. 2007. Haplotype diversity in source-sink dynamics of Escherichia coli urovirulence. J. Mol. Evol. 64:204-214.
27. Brisse S, Diancourt L, Laouenan C, Vigan M, Caro V, Arlet G, Drieux L, Leflon-Guibout V, Mentre F, Jarlier V, Nicolas-Chanoine M. 2012. Phylogenetic distribution of CTX-M and non-extended-spectrum betalactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes. J. Clin. Microbiol. 50: 2974-2981.